AVEO Oncology
Biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD875m (Public information from Oct 2022)
Cambridge Massachusetts (HQ)
Authorizing premium user...